Tranexamic acid for safer surgery: does the evidence support preventative use? Response to Br J Anaesth 2023; 130: e23-e24.

Grocott, Michael P W; Murphy, Mike; Roberts, Ian; Sayers, Rob; Toh, Cheng-Hock

Grocott, Michael P W; Murphy, Mike; Roberts, Ian; Sayers, Rob; Toh, Cheng-Hock.

Afiliação

Grocott MPW; NIHR Southampton Biomedical Research Centre, University Hospital Southampton/University of Southampton, Southampton, UK; Royal College of Anaesthetists, London, UK.
Murphy M; NHS Blood and Transplant, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; University of Oxford, Oxford, UK.
Roberts I; Clinical Trials Unit, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: Ian.Roberts@lshtm.ac.uk.
Sayers R; University of Leicester, Leicester, UK; Royal College of Surgeons of England, London, UK.
Toh CH; University of Liverpool, Liverpool, UK; Royal College of Physicians, London, UK.

Br J Anaesth ; 130(2): e195-e196, 2023 02.

Article em En | MEDLINE | ID: mdl-36522217

Assuntos

Antifibrinolíticos; Ácido Tranexâmico; Humanos; Ácido Tranexâmico/uso terapêutico; Antifibrinolíticos/uso terapêutico; Hemorragia Gastrointestinal; Perda Sanguínea Cirúrgica

Palavras-chave

bleeding; clinical trial; patient blood management; surgical bleeding; thromboembolic events; tranexamic acid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Tranexâmico / Antifibrinolíticos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google